The KREX™ platform delivers precision antibody profiling with correctly folded, highly multiplexed proteins.
Sengenics is a leading biotechnology company committed to advancing precision medicine through innovative antibody profiling solutions. With its proprietary KREX™ platform, Sengenics delivers high-quality, multiplexed protein analysis that drives breakthroughs in drug response prediction, autoimmune disease research, and biomarker discovery.
Located in Wilmington, Delaware, Sengenics is dedicated to providing cutting-edge technologies and services to researchers and clinicians worldwide. The company's expertise in immunoproteomics and custom protein expression enables comprehensive immune response analysis, patient stratification, and vaccine screening.
Sengenics's primary address is in Wilmington, Delaware 19801, US. We invite the management team at Sengenics to enrich this profile further with a customized company showcase and detailed product listings on our platform, highlighting the full scope of their capabilities and contributions to the biotechnology field.
Sengenics est une entreprise de biotechnologie de premier plan qui s'engage à faire progresser la médecine de précision grâce à des solutions innovantes de profilage d'anticorps. Grâce à sa plateforme exclusive KREX™, Sengenics offre une analyse de protéines multiplexée de haute qualité qui favorise les percées dans la prédiction de la réponse aux médicaments, la recherche sur les maladies auto-immunes et la découverte de biomarqueurs.
Située à Wilmington, dans le Delaware, Sengenics se consacre à fournir des technologies et des services de pointe aux chercheurs et aux cliniciens du monde entier. L'expertise de l'entreprise en matière d'immunoprotéomique et d'expression de protéines personnalisées permet une analyse complète de la réponse immunitaire, la stratification des patients et le criblage des vaccins.
L'adresse principale de Sengenics est Wilmington, Delaware 19801, US. Nous invitons l'équipe de direction de Sengenics à enrichir davantage ce profil avec une présentation personnalisée de l'entreprise et des listes de produits détaillées sur notre plateforme, soulignant ainsi l'étendue de leurs capacités et leurs contributions au domaine de la biotechnologie.
Compare Sengenics with 3 companies in Biotechnology
| Comparison Field |
SengenicsMain Company |
CytoReasonView Profile |
International Societ...View Profile |
Proteomica Internati...View Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 2016 | 1999 | |
|
Company Size
|
— | 51-200 | 2-10 | 2-10 |
|
City
|
Wilmington, Delaware | Vancouver, BC | Mumbai, Maharastra | |
|
Country
|
United States | Canada | India | |
|
Skills & Keywords
Comparing with main company
|
17 Total Skills
Biotechnology
Antibody Profiling
Precision Medicine
Drug Response Prediction
Autoimmune Disease
Biomarker Discovery
Immunoproteomics
Autoantibody Profiling
Immune Response to Disease
Patient Stratification
Custom Protein Expression
Immuno-Oncology
Cancer Immunotherapy
Autoantibody Biomarker Discovery
Custom Arrays
Vaccine Screening
Protein Arrays
|
13 Total
13 Unique
Unique Skills:
Artificial Intelligence
Atopic Dermatitis
Bioinformatics
Cells
Combinations
Computational Drug Discovery
+7
|
9 Total
1 Common
8 Unique
Match
6%
Common Skills:
Biotechnology
Unique Skills:
Best Practices
Biobanking
Informatics
Laboratory Medicine
Networking
Proficiency Testing
+2
|
10 Total
1 Common
9 Unique
Match
6%
Common Skills:
Biotechnology
Unique Skills:
Biologics
Biotherapeutics
Clinical Diagonistics
Drug Discovery & Devopment
Early disease prediction & prognosis
Impurity Detection
+3
|
Other organizations in the same industry
This company is also known as